482 related articles for article (PubMed ID: 29454311)
1. Radiotherapy related skin toxicity (RAREST-01): Mepitel® film versus standard care in patients with locally advanced head-and-neck cancer.
Narvaez C; Doemer C; Idel C; Setter C; Olbrich D; Ujmajuridze Z; Carl JH; Rades D
BMC Cancer; 2018 Feb; 18(1):197. PubMed ID: 29454311
[TBL] [Abstract][Full Text] [Related]
2. Radiotherapy-related skin toxicity (RAREST-02): A randomized trial testing the effect of a mobile application reminding head-and-neck cancer patients to perform skin care (reminder app) on radiation dermatitis.
Rades D; Narvaez CA; Doemer C; Janssen S; Olbrich D; Tvilsted S; Conde-Moreno AJ; Cacicedo J
Trials; 2020 May; 21(1):424. PubMed ID: 32450921
[TBL] [Abstract][Full Text] [Related]
3. A randomized trial (RAREST-01) comparing Mepitel® Film and standard care for prevention of radiation dermatitis in patients irradiated for locally advanced squamous cell carcinoma of the head-and-neck (SCCHN).
Rades D; Narvaez CA; Splettstößer L; Dömer C; Setter C; Idel C; Ribbat-Idel J; Perner S; Bartscht T; Olbrich D; Schild SE; Carl J
Radiother Oncol; 2019 Oct; 139():79-82. PubMed ID: 31431372
[TBL] [Abstract][Full Text] [Related]
4. Topical steroid versus placebo for the prevention of radiation dermatitis in head and neck cancer patients receiving chemoradiotherapy: the study protocol of J-SUPPORT 1602 (TOPICS study), a randomized double-blinded phase 3 trial.
Zenda S; Yamaguchi T; Yokota T; Miyaji T; Mashiko T; Tanaka M; Yonemura M; Takeno M; Okano T; Kawasaki T; Nakamori Y; Ishii S; Shimada S; Kanamaru M; Uchitomi Y
BMC Cancer; 2018 Sep; 18(1):873. PubMed ID: 30189840
[TBL] [Abstract][Full Text] [Related]
5. Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck.
Bernier J; Bonner J; Vermorken JB; Bensadoun RJ; Dummer R; Giralt J; Kornek G; Hartley A; Mesia R; Robert C; Segaert S; Ang KK
Ann Oncol; 2008 Jan; 19(1):142-9. PubMed ID: 17785763
[TBL] [Abstract][Full Text] [Related]
6. Hypericum perforatum and neem oil for the management of acute skin toxicity in head and neck cancer patients undergoing radiation or chemo-radiation: a single-arm prospective observational study.
Franco P; Potenza I; Moretto F; Segantin M; Grosso M; Lombardo A; Taricco D; Vallario P; Filippi AR; Rampino M; Ricardi U
Radiat Oncol; 2014 Dec; 9():297. PubMed ID: 25544371
[TBL] [Abstract][Full Text] [Related]
7. A monocentric, open-label randomized standard-of-care controlled study of XONRID®, a medical device for the prevention and treatment of radiation-induced dermatitis in breast and head and neck cancer patients.
Ingargiola R; De Santis MC; Iacovelli NA; Facchinetti N; Cavallo A; Ivaldi E; Dispinzieri M; Franceschini M; Giandini C; Romanello DA; Di Biaso S; Sabetti M; Locati L; Alfieri S; Bossi P; Guglielmo M; Macchi F; Lozza L; Valdagni R; Fallai C; Pignoli E; Orlandi E
Radiat Oncol; 2020 Aug; 15(1):193. PubMed ID: 32791985
[TBL] [Abstract][Full Text] [Related]
8. Topical use of Jiawei Simiao Yongan Gao to prevent radiodermatitis in patients with head and neck cancer: A retrospective cohort study.
Song F; Liao Z; Li T; Kang N; Li Z; Fan S; Liu F
Medicine (Baltimore); 2020 Nov; 99(48):e23318. PubMed ID: 33235092
[TBL] [Abstract][Full Text] [Related]
9. Do selective radiation dose escalation and tumour hypoxia status impact the loco-regional tumour control after radio-chemotherapy of head & neck tumours? The ESCALOX protocol.
Pigorsch SU; Wilkens JJ; Kampfer S; Kehl V; Hapfelmeier A; Schläger C; Bier H; Schwaiger M; Combs SE
Radiat Oncol; 2017 Mar; 12(1):45. PubMed ID: 28249612
[TBL] [Abstract][Full Text] [Related]
10. DeCoP, a Dermatitis Control Program using a moderately absorbent surgical pad for head and neck cancer patients receiving radiotherapy: a retrospective analysis.
Zenda S; Ishi S; Akimoto T; Arahira S; Motegi A; Tahara M; Hayashi R; Asanuma C
Jpn J Clin Oncol; 2015 May; 45(5):433-8. PubMed ID: 25673153
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of irradiation and cetuximab induced skin reactions in patients with locally advanced head and neck cancer undergoing radioimmunotherapy: the HICARE protocol (head and neck cancer: immunochemo and radiotherapy with erbitux) - a multicenter phase IV trial.
Habl G; Potthoff K; Haefner MF; Abdollahi A; Hassel JC; Boller E; Indorf M; Debus J
BMC Cancer; 2013 Jul; 13():345. PubMed ID: 23855804
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic NS-21 maintains the skin moisture but does not reduce the severity of radiation dermatitis in patients with head and neck cancer: a randomized control trial.
Chou HL; Shueng PW; Liao LJ; Hsu CX; Kuo DY; Lo WC; Hou PY; Wang LY; Chou SF; Hsieh CH
Radiat Oncol; 2019 May; 14(1):90. PubMed ID: 31146741
[TBL] [Abstract][Full Text] [Related]
13. The effect of Mepitel Film on acute radiation-induced skin reactions in head and neck cancer patients: a feasibility study.
Wooding H; Yan J; Yuan L; Chyou TY; Gao S; Ward I; Herst PM
Br J Radiol; 2018 Jan; 91(1081):20170298. PubMed ID: 29072852
[TBL] [Abstract][Full Text] [Related]
14. Effect of HMB/Arg/Gln on the prevention of radiation dermatitis in head and neck cancer patients treated with concurrent chemoradiotherapy.
Imai T; Matsuura K; Asada Y; Sagai S; Katagiri K; Ishida E; Saito D; Sadayasu R; Wada H; Saijo S
Jpn J Clin Oncol; 2014 May; 44(5):422-7. PubMed ID: 24688085
[TBL] [Abstract][Full Text] [Related]
15. Impact of a mobile application (reminder app) on acute toxicity during radiotherapy of head-and-neck cancer - results of a randomized phase III trial (RAREST-02).
Rades D; Zwaan I; Cacicedo J; Bruchhage KL; Hakim SG; Olbrich D; Schild SE; Tvilsted S; Janssen S
BMC Cancer; 2022 Sep; 22(1):989. PubMed ID: 36115962
[TBL] [Abstract][Full Text] [Related]
16. Management of severe bio-radiation dermatitis induced by radiotherapy and cetuximab in patients with head and neck cancer: emphasizing the role of calcium alginate dressings.
Bonomo P; Desideri I; Loi M; Ciccone LP; Lo Russo M; Becherini C; Greto D; Simontacchi G; Pimpinelli N; Livi L
Support Care Cancer; 2019 Aug; 27(8):2957-2967. PubMed ID: 30569265
[TBL] [Abstract][Full Text] [Related]
17. Management of radiation dermatitis in patients receiving cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: proposals for a revised grading system and consensus management guidelines.
Bernier J; Russi EG; Homey B; Merlano MC; Mesía R; Peyrade F; Budach W
Ann Oncol; 2011 Oct; 22(10):2191-200. PubMed ID: 21606209
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
19. A single-blind, randomised controlled trial of StrataXRT® - A silicone-based film-forming gel dressing for prophylaxis and management of radiation dermatitis in patients with head and neck cancer.
Chan RJ; Blades R; Jones L; Downer TR; Peet SC; Button E; Wyld D; McPhail S; Doolan M; Yates P
Radiother Oncol; 2019 Oct; 139():72-78. PubMed ID: 31445838
[TBL] [Abstract][Full Text] [Related]
20. Panitumumab plus radiotherapy versus chemoradiotherapy in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-2): a randomised, controlled, open-label phase 2 trial.
Giralt J; Trigo J; Nuyts S; Ozsahin M; Skladowski K; Hatoum G; Daisne JF; Yunes Ancona AC; Cmelak A; Mesía R; Zhang A; Oliner KS; VanderWalde A
Lancet Oncol; 2015 Feb; 16(2):221-32. PubMed ID: 25596659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
